Nephros (NEPH) Profit After Tax (QoQ) (2010 - 2026)
Nephros (NEPH) Profit After Tax (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 127.18 Bn | 121.97 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.82 Bn | 44.00 Bn | 2.15 Bn |
| 3 | Alcon | 33.06 Bn | 31.40 Bn | 1.53 Bn |
| 4 | Medline | 32.89 Bn | 30.65 Bn | 1.84 Bn |
| 5 | Resmed | 29.34 Bn | 27.68 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.37 Bn | 22.94 Bn | 329.20 Mn |
| 7 | Solventum | 14.11 Bn | 13.54 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.79 Bn | 13.65 Bn | 735.40 Mn |
| 9 | Align Technology | 12.07 Bn | 11.01 Bn | 736.59 Mn |
| 10 | Nephros | 36.20 Mn | 32.18 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 125.81% |
| Dec 31, 2025 | -81.60% |
| Sep 30, 2025 | 42.19% |
| Jun 30, 2025 | -57.53% |
| Mar 31, 2025 | 59.89% |
| Dec 31, 2024 | 90.71% |
| Sep 30, 2024 | 163.32% |
| Jun 30, 2024 | -71.01% |
| Mar 31, 2024 | 74.16% |
| Dec 31, 2023 | -259.34% |
| Sep 30, 2023 | 57.97% |
| Jun 30, 2023 | -41.50% |
| Mar 31, 2023 | -115.45% |
| Dec 31, 2022 | 162.81% |
| Sep 30, 2022 | -177.40% |
| Jun 30, 2022 | 42.20% |
| Mar 31, 2022 | -130.06% |
| Dec 31, 2021 | 26.67% |
| Sep 30, 2021 | -3.55% |
| Jun 30, 2021 | -109.68% |